Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.

Where this comes from

• Record sourced from PubMed, PMID 29020105.
• Also identified by DOI 10.1371/journal.pone.0186531 and PMC identifier 5636148.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.